Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Hoerger

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Medical Care|June 19, 2009
Using costs in cost-effectiveness models for chronic diseases: lessons from diabetesThomas J Hoerger
Current Diabetes Reports|May 1, 2019
Economics and Policy in Bariatric SurgeryThomas J Hoerger
Journal of Managed Care Pharmacy : JMCP|February 5, 2008
The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomesThomas J Hoerger, Andrew J Ahmann
American Journal of Preventive Medicine|August 20, 2013
Lifetime direct medical costs of treating type 2 diabetes and diabetic complicationsXiaohui Zhuo, Ping Zhang, Thomas J Hoerger
Preventing Chronic Disease|October 19, 2011
A cost-benefit analysis of lipid standardization in the United StatesThomas J Hoerger, John S Wittenborn, Walter Young
Health Services Research|February 6, 2008
Use of econometric models to estimate expenditure sharesJustin G Trogdon, Eric A Finkelstein, Thomas J Hoerger
North Carolina Medical Journal|October 29, 2015
Can Incentives Improve Medicaid Patient Engagement and Prevent Chronic Diseases?Thomas J Hoerger, Rebecca Perry, Kathleen Farrell, et al.
Diabetes Care|March 25, 2010
Cost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetesRui Li, Ping Zhang, Lawrence E Barker, et al.
Preventing Chronic Disease|December 29, 2022
Postdelivery Intervention to Prevent Type 2 Diabetes and the Cost-Effectiveness of Screening Criteria for Gestational DiabetesSimon J Neuwahl, Andrea J Sharma, Ping Zhang, et al.
BMJ Open Diabetes Research & Care|November 10, 2017
Identifying risk for type 2 diabetes in different age cohorts: does one size fit all?Maria L Alva, Thomas J Hoerger, Ping Zhang, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Medical Care|June 19, 2009
Using costs in cost-effectiveness models for chronic diseases: lessons from diabetesThomas J Hoerger
Current Diabetes Reports|May 1, 2019
Economics and Policy in Bariatric SurgeryThomas J Hoerger
Journal of Managed Care Pharmacy : JMCP|February 5, 2008
The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomesThomas J Hoerger, Andrew J Ahmann
American Journal of Preventive Medicine|August 20, 2013
Lifetime direct medical costs of treating type 2 diabetes and diabetic complicationsXiaohui Zhuo, Ping Zhang, Thomas J Hoerger
Preventing Chronic Disease|October 19, 2011
A cost-benefit analysis of lipid standardization in the United StatesThomas J Hoerger, John S Wittenborn, Walter Young
Health Services Research|February 6, 2008
Use of econometric models to estimate expenditure sharesJustin G Trogdon, Eric A Finkelstein, Thomas J Hoerger
North Carolina Medical Journal|October 29, 2015
Can Incentives Improve Medicaid Patient Engagement and Prevent Chronic Diseases?Thomas J Hoerger, Rebecca Perry, Kathleen Farrell, et al.
Diabetes Care|March 25, 2010
Cost-effectiveness of aspirin use among persons with newly diagnosed type 2 diabetesRui Li, Ping Zhang, Lawrence E Barker, et al.
Preventing Chronic Disease|December 29, 2022
Postdelivery Intervention to Prevent Type 2 Diabetes and the Cost-Effectiveness of Screening Criteria for Gestational DiabetesSimon J Neuwahl, Andrea J Sharma, Ping Zhang, et al.
BMJ Open Diabetes Research & Care|November 10, 2017
Identifying risk for type 2 diabetes in different age cohorts: does one size fit all?Maria L Alva, Thomas J Hoerger, Ping Zhang, et al.
Pageof 7